News
Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, late-stage biotechnology company advancing a sustainable ...
We recently published a list of 10 Stocks Under $10 that Will Triple. In this article, we are going to take a look at where ...
3d
India Today on MSNIndia's Skyroot successfully fires Kalam-100 to power Vikram-1 rocket to spaceThis test builds upon previous successes, including a fixed-nozzle static fire test, demonstrating Skyroot’s technological ...
10d
India Today on MSNVideo: Spectrum rocket dramatically crashes seconds after maiden launchDramatic footage captured the Spectrum rocket spiraling out of control before plummeting to the ground and exploding in a fireball.
Isar Aerospace's Spectrum rocket recently failed to launch, exploding and crashing just 18 seconds into its first flight, ...
While the Ukrainian military—industrial complex in the western regions and Eastern Europe continues to work at full capacity, ...
Skyroot has designed Vikram-1 to support flexible, rapid satellite deployment. The rocket is intended to deliver up to 480 ...
Teacher Retirement System of Texas raised its position in shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Free Report) by 45.2% during the 4th quarter, Holdings Channel reports. The fund owned ...
Hyderabad: Skyroot Aerospace, a leading Indian private space company, has successfully completed the static fire test of the ...
Hosted on MSN29d
BMO Capital Initiates Coverage of Rocket Pharmaceuticals (RCKT) with Outperform RecommendationRocket's clinical programs using lentiviral vector (LVV)-based gene therapy are for the treatment of Fanconi Anemia (FA), a difficult to treat genetic disease that leads to bone marrow failure and ...
Skyroot Aerospace, a Hyderabad-based spacetech startup, successfully tested the third stage of its Vikram-1 rocket, named ...
Making a giant leap towards orbit, Hyderabad-based spacetech startup <br />Skyroot Aerospace has successfully tested the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results